Skip to main content

Table 1 Inclusion and exclusion criteria for participation in Managing Diabetes in a ‘Flash’

From: Effect of 6 months’ flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a ‘flash’ randomised controlled trial protocol

Inclusion criteria

Exclusion criteria

• Aged 13 to 20 years (inclusive)

• Any severe diabetes related complications (nephropathy on treatment, retinopathy with associated visual loss – milder degrees will not be excluded)

• Mean HbA1c over previous 6 months ≥75 mmol/mol (≥9%)

• Diagnosed with T1D for at least 12 months

• Other severe uncontrolled medical or psychiatric co-morbidity/severe mental illness

• Prescribed > 0.5 units of insulin/kg/day (with no restrictions based on insulin regimen)

• Planned to continue with routine clinical care during the initial 6-month RCT

• Currently using a CGM or FGM device or has used one continuously (other than for intermittent hospital use) within the previous 4 months

• Resident in and expecting to remain in regions affiliated with the Canterbury, Capital and Coast, and Southern District Health Boards for the following year

• Participation in another device or drug study that could affect glucose measurements during the study period

• Pregnant, lactating, or plan to become pregnant

• Ability to understand study procedures, including English language proficiency, and to comply with them for the entire length of the study

• Inability of individual (for those aged 16 years and older) or legal guardian (for those aged 13–15 years) to give written informed consent